Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2001-2-9
pubmed:abstractText
Elimination of both alleles of the gene that encodes the cyclin kinase inhibitor p21(WAF1/cip1) increases the frequency and size of intestinal tumors in Apc1638+/- mice that inherit a mutant allele of the Apc gene, and intermediate effects are seen if a single p21 allele is inactivated. The increased tumor formation is associated with altered cell maturation in the intestinal mucosa of the p21-deficient mice--increased cell proliferation, and decreased apoptosis, and goblet cell differentiation--that is also a function of p21 gene dosage. Moreover, a Western-style diet that mimics principal risk factors for colon cancer (high fat and phosphate, low calcium and vitamin D) accelerates tumor formation in Apc1638+/- mice, and the loss of a single or both p21 alleles is additive with the tumor-promoting effects of this diet, resulting in more and larger tumors, and a highly significant decrease in survival time. Thus, p21 normally suppresses Apc-initiated tumor formation and is haplo-insufficient in this regard. This is consistent with recent reports that Apc initiates tumor formation by up-regulating c-myc expression through altered beta-catenin-Tcf signaling and that c-myc then up-regulates cdk4, whose activity is inhibited by p21. Decreased expression of p21 is also a marker of poor prognosis in patients, and the data presented suggest that dietary alterations in patients undergoing treatment for colon cancer might be highly effective in improving outcome.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
565-9
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11212250-Adenomatous Polyposis Coli Protein, pubmed-meshheading:11212250-Animals, pubmed-meshheading:11212250-Apoptosis, pubmed-meshheading:11212250-Cell Differentiation, pubmed-meshheading:11212250-Cell Division, pubmed-meshheading:11212250-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:11212250-Cyclins, pubmed-meshheading:11212250-Cytoskeletal Proteins, pubmed-meshheading:11212250-Diet, pubmed-meshheading:11212250-Female, pubmed-meshheading:11212250-Gastrointestinal Neoplasms, pubmed-meshheading:11212250-Gene Silencing, pubmed-meshheading:11212250-Genotype, pubmed-meshheading:11212250-Immunohistochemistry, pubmed-meshheading:11212250-Intestinal Mucosa, pubmed-meshheading:11212250-Male, pubmed-meshheading:11212250-Mice, pubmed-meshheading:11212250-Mice, Mutant Strains, pubmed-meshheading:11212250-Mucins, pubmed-meshheading:11212250-Mutation, pubmed-meshheading:11212250-Proliferating Cell Nuclear Antigen, pubmed-meshheading:11212250-Survival Analysis
pubmed:year
2001
pubmed:articleTitle
Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.
pubmed:affiliation
Albert Einstein Cancer Center, Bronx, New York 10467, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.